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We assessed awareness of human papillomavirus (HPV) in a population sample of British women (n¼1620) using similar questions
to those in a survey in 2002. Only 2.5% cited HPV as the cause of cervical cancer without prompting; up from 0.9% in 2002. Public
education about HPV is urgently needed.
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There has been dramatic progress in understanding the role of
human papillomavirus (HPV) in the aetiology of cervical cancer
(Bosch and de Sanjose ´, 2003). Human papillomavirus testing is
likely to play a part in screening for cervical abnormalities (Cuzick
et al, 2006). Prophylactic HPV vaccination has been shown to be
highly effective at preventing infection (Villa et al, 2005), and is
likely to be introduced in the United Kingdom in the near future.
Despite the important public health implications of this work,
knowledge about HPV in the general public appears to be low.
Although surveys in Britain indicate that around 30% of young
adults have ‘heard of’ HPV (Philips et al, 2003; Waller et al, 2003),
this is probably little more than name recognition, because further
questioning of women who say they are aware, found that fewer
than half knew of the link with cervical cancer (Waller et al, 2003;
Tiro et al, 2007). Using the open question ‘What causes cervical
cancer’, the percentage mentioning HPV was less than 2% in
surveys in the United Kingdom and Mexico (Lazcano-Ponce et al,
2001; Waller et al, 2004).
The potential for a prophylactic vaccine has attracted a great
deal of press coverage, and this may have increased knowledge of
HPV. However, internet and newspaper articles are most likely to
be accessed by higher SES groups (Pew Internet & American Life
Project, 2006), so the educational impact could be stronger in more
educated groups.
The present study assessed awareness of HPV and knowledge of
risk factors for cervical cancer in home-based interviews with a
population-representative sample of British women. Responses
were compared with results from a survey carried out in 2002 that
used similar methods (Waller et al, 2004), making it possible to
analyse changes over time.
MATERIALS AND METHODS
Participants were women aged 16–97 years from a stratified
random probability sampling frame. Data were collected as part of
the NatCen (National Centre for Social Research) omnibus survey.
Using the Post Office Address File (PAF), 6100 addresses in
England, Wales and Scotland were selected for recruitment
between November 2006 and February 2007. The selected
addresses were sent a letter informing them about the research.
Data were collected during face-to-face computer-assisted
interviews.
Women were first asked an open question; ‘Thinking of cervical
cancer, what do you think is its main cause’. This was followed by
‘What, if any, are other causes of cervical cancer’. Women were
prompted using the phrase ‘anything else’ to encourage multiple
responses. This was the same format as used in the 2002 survey
(Waller et al, 2004). After that, women were asked a ‘closed’
awareness question: ‘Before this interview, were you aware of
HPV’. This was asked after the open question to avoid it
influencing their answers. Demographic information, including
age, ethnicity, educational attainment and income, was also
collected.
Data were analysed using SPSS version 14.0. To assess
associations between demographic factors and HPV awareness,
each variable was entered individually into a logistic regression
analysis. Data from the recall question were recoded so that any
mention of a risk factor was included in the analysis and results
were merged with the data from 2002 to analyse changes over time.
Chi-square (w
2) analyses revealed some socio-demographic differ-
ences between the two samples, so log-linear analysis was used,
controlling for potentially confounding variables.
RESULTS
There were 5585 eligible addresses at which 2981 productive
interviews were carried out (response rate¼53.4%). The questions
in this survey were only asked in interviews with women
(n¼1620), but the recruitment method meant that response rates
could only be calculated for both sexes. Respondents were aged 50
years on average and most were white (94%). See Table 1 for a
breakdown of sample characteristics.
Awareness of HPV (recognition)
On the basis of the simple question about awareness of HPV that
was asked at the end of the interview (the term ‘HPV’ was not used
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ypreviously by the interviewer), a quarter of participants (24.2%,
n¼388) said they were aware of HPV. There were some age
differences, with 29% of respondents who were in the cervical
cancer screening age (25–64 years) reporting awareness of HPV
compared with only 15% aged 16–24 years or 65 and over.
Differences in HPV awareness by ethnic group were not
significant, but awareness was lower in respondents with lower
levels of education and income (see Table 1).
Recall of cervical cancer risk factors
Responses to the ‘open’ question about causes of cervical cancer
are shown in Table 2. Around half of respondents answered ‘don’t
know’ (51%), and only 2.5% mentioned HPV. Compared with
those with no formal education, respondents were more likely to
mention HPV if they were educated to A-level standard (OR¼3.75,
CI 1.05–13.41) or had a University degree (OR¼10.28, CI 3.37–
31.36). Respondents were also more likely to mention HPV if they
had an annual income greater than d30000 than if their income
was less than d10000 (OR¼5.66, CI 2.34–13.72).
Overall, 28% of respondents identified something associated
with sexual activity: multiple sexual partners (14%), unspecified
sexually transmitted virus/infection (7%), sex at a young age (7%),
frequency of sex (3%), not using condoms (3%) or unspecified
sexual activity (4%). Other sexually transmitted diseases (wart
virus, genital warts, herpes, chlamydia and HIV/AIDS) were cited
by 2% of respondents. Additional responses included a virus/
infection not specifying transmission type (5%), smoking (7%),
and not going for regular screening (5%).
Change in knowledge of cervical cancer risk factors over
time
Respondents from 2007 had slightly higher incomes (w
2(3)¼9.36,
P¼0.025) and were less likely to be in ethnic minority groups
(w
2(4)¼14.36, P¼0.006) than respondents from 2002. Further
analyses controlled for these variables.
Compared with results from 2002, there was a modest but
significant increase in the number of respondents citing HPV as a
risk factor for cervical cancer (from 0.9 in 2002 to 2.5% in 2007),
and an increase in the number of respondents who mentioned
virus/infection (from 2 to 5%). However, fewer respondents
mentioned other factors relating to sexual activity, including
number of sexual partners (2002: 30%, 2007: 14%), sex at a young
age (13–7%), and not using condoms (7–3%). There were also
significant decreases in citing wart virus (2–1%), genital warts
(2–1%), not attending for smears (15–5%), smoking (15–7%), the
pill (7–1%), older age (2–1%) and family history of cervical
cancer (16–8%).
DISCUSSION
In this survey, a quarter of respondents answered ‘yes’ to the
question ‘Were you aware of HPV’; which is similar to previous
findings in selected samples in the United Kingdom (Waller et al,
2003). As predicted, awareness was lower in those with less formal
education, similar to disparities observed in knowledge about risk
factors for other preventable cancers such as lung and skin
(Viswanath et al, 2006).
Despite relatively high HPV name recognition, only 2.5% of
respondents could spontaneously name HPV as a cause of cervical
cancer, although this represents nearly a three-fold increase since
2002. There was also an increase in the proportion of respondents
who mentioned virus/infection as a risk factor, but no increase in
mention of ‘a sexually transmitted’ virus/infection. These results
suggest that information about the viral aetiology of cervical
cancer has trickled into the population since 2002, but under-
standing of how the virus is transmitted has not improved. It is
striking that despite all the publicity about HPV, the percentage of
Table 1 Demographic characteristics of the sample and associations with HPV awareness (‘aware of HPV’)
Awareness of HPV Significance
% N OR (95% CI) P-value
Age
16–24 (n¼138) 15.2 21 1.00
25–34 (n¼260) 27.0 70 2.06 (1.20–3.54) 0.008
35–44 (n¼307) 29.0 85 2.16 (1.28–3.67) 0.004
45–54 (n¼262) 30.8 80 2.48 (1.45–4.22) 0.001
55–64 (n¼252) 29.9 75 2.37 (1.39–4.06) 0.002
65–74 (n¼210) 18.9 39 1.30 (0.73–2.33) 0.374
75+ (n¼191) 9.6 18 0.59 (0.30–1.16) 0.128
Ethnicity
White (n¼1521) 24.2 366 1.00
Asian or mixed Asian (n¼38) 23.7 9 0.97 (0.46–2.07) 0.941
Black or mixed black (n¼35) 17.6 6 0.67 (0.28–1.63) 0.379
Other (n¼15) 20.0 3 0.78 (0.22–2.79) 0.783
Education
No formal qualifications (n¼536) 12.7 67 1.00
CSE/O-level (or equivalent) (n¼466) 17.5 81 1.46 (1.03–2.07) 0.035
A-level (or equivalent) (n¼219) 27.1 59 2.55 (1.72–3.79) o.001
Higher education below degree (n¼177) 49.4 87 6.73 (4.55–9.95) o.001
Degree (n¼209) 44.9 93 5.61 (3.86–8.17) o.001
Respondent income
o d10000 (n¼763) 18.9 144 1.00
d10000-d19999 (n¼357) 24.8 88 1.41 (1.05–1.91) 0.025
d20000-d29999 (n¼150) 42.3 63 3.14 (2.16–4.55) 0.000
4d30000 (n¼74) 46.6 34 3.74 (2.28–6.12) 0.000
Missing (n¼276) 22.1 59 1.22 (0.86–1.71) 0.263
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ythe population who can recall that a viral infection is involved in
cervical cancer, let alone which infection, is still extraordinarily
low (o10%). What has also emerged, as predicted, is a significant
SES gradient in awareness of HPV.
Public understanding of HPV is necessary to ensure informed
consent for vaccination and testing. There is therefore an urgent
need for educational programmes. Given that lower SES is known
to be associated with lower attendance at cervical screening (e.g.,
Webb et al, 2004), raising awareness about HPV in these groups is
particularly important. Health education initiatives should include
specific efforts to reach lower SES groups, who have the lowest
awareness but are at greatest risk.
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